Utility of the CPS plus EG scoring system in triple-negative breast cancer treated with neoadjuvant chemotherapy

Marme F, Solbach C, Michel L, Fasching P, Schneeweiss A, Blohmer JU, Rezai M, Huober J, Jackisch C, Nekljudova V, Link T, Rhiem K, Denkert C, Hanusch C, Tesch H, Lederer B, Loibl S, Untch M (2019)

Publication Type: Conference contribution

Publication year: 2019

Journal

Annals of Oncology Elsevier

Publisher: OXFORD UNIV PRESS

City/Town: OXFORD

Pages Range: 58-+

Conference Proceedings Title: ANNALS OF ONCOLOGY

Event location: Barcelona ES

DOI: 10.1093/annonc/mdz240.008

Authors with CRIS profile

Peter Fasching Professur für Translationale Frauenheilkunde und Geburtshilfe

Involved external institutions

Universitätsklinikum Heidelberg DE Germany (DE) Universität Ulm DE Germany (DE) Charité - Universitätsmedizin Berlin DE Germany (DE) Universitätsklinikum Frankfurt am Main (KGU) DE Germany (DE) GBG Forschungs GmbH (German Breast Group) DE Germany (DE) Sana Kliniken AG DE Germany (DE) Philipps-Universität Marburg DE Germany (DE) Universitätsklinikum Carl Gustav Carus Dresden DE Germany (DE) Universitätsklinikum Köln DE Germany (DE) HELIOS Kliniken DE Germany (DE) Universitätsklinikum Mannheim DE Germany (DE) Luisenkrankenhaus Düsseldorf DE Germany (DE) Nationales Centrum für Tumorerkrankungen (NCT) Heidelberg DE Germany (DE) Rotkreuzklinikum München DE Germany (DE)

How to cite

APA:

Marme, F., Solbach, C., Michel, L., Fasching, P., Schneeweiss, A., Blohmer, J.-U.,... Untch, M. (2019). Utility of the CPS plus EG scoring system in triple-negative breast cancer treated with neoadjuvant chemotherapy. In ANNALS OF ONCOLOGY (pp. 58-+). Barcelona, ES: OXFORD: OXFORD UNIV PRESS.

MLA:

Marme, F., et al. "Utility of the CPS plus EG scoring system in triple-negative breast cancer treated with neoadjuvant chemotherapy." Proceedings of the 44th Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona OXFORD: OXFORD UNIV PRESS, 2019. 58-+.

BibTeX: Download